机译:CRP / PRELBumin,一种新型炎症指数,用于预测胃癌患者激进切除后的复发性:后性能分析了随机期III试验
Fujian Med Univ Dept Gastr Surg Union Hosp 29 Xinquan Rd Fuzhou 350001 Fujian Peoples R China;
Fujian Med Univ Dept Gastr Surg Union Hosp 29 Xinquan Rd Fuzhou 350001 Fujian Peoples R China;
Fujian Med Univ Dept Gastr Surg Union Hosp 29 Xinquan Rd Fuzhou 350001 Fujian Peoples R China;
Fujian Med Univ Dept Gastr Surg Union Hosp 29 Xinquan Rd Fuzhou 350001 Fujian Peoples R China;
Fujian Med Univ Dept Gastr Surg Union Hosp 29 Xinquan Rd Fuzhou 350001 Fujian Peoples R China;
Fujian Med Univ Dept Gastr Surg Union Hosp 29 Xinquan Rd Fuzhou 350001 Fujian Peoples R China;
Fujian Med Univ Dept Gastr Surg Union Hosp 29 Xinquan Rd Fuzhou 350001 Fujian Peoples R China;
Fujian Med Univ Dept Gastr Surg Union Hosp 29 Xinquan Rd Fuzhou 350001 Fujian Peoples R China;
Fujian Med Univ Dept Gastr Surg Union Hosp 29 Xinquan Rd Fuzhou 350001 Fujian Peoples R China;
Fujian Med Univ Dept Gastr Surg Union Hosp 29 Xinquan Rd Fuzhou 350001 Fujian Peoples R China;
Fujian Med Univ Dept Gastr Surg Union Hosp 29 Xinquan Rd Fuzhou 350001 Fujian Peoples R China;
Fujian Med Univ Dept Gastr Surg Union Hosp 29 Xinquan Rd Fuzhou 350001 Fujian Peoples R China;
Fujian Med Univ Dept Gastr Surg Union Hosp 29 Xinquan Rd Fuzhou 350001 Fujian Peoples R China;
Fujian Med Univ Dept Gastr Surg Union Hosp 29 Xinquan Rd Fuzhou 350001 Fujian Peoples R China;
Gastric cancer; Inflammatory index; CRP; prealbumin; Recurrence; Post-recurrence survival;
机译:CRP / PRELBumin,一种新型炎症指数,用于预测胃癌患者激进切除后的复发性:后性能分析了随机期III试验
机译:验证先前报告的辐射诱导的鼻咽癌患者的甲状腺功能亢进症患者预测因子,从强度调制的放射治疗治疗,III期随机试验的后HOC分析(Vol 59,PG 446,2018)
机译:来自III期随机试验的事后分析:先前报道的接受强度调节放射治疗的鼻咽癌患者放射诱发甲状腺功能减退的预测因子的验证
机译:径向基函数人工神经网络预测食管胃交界处癌症患者的术前和术后复发
机译:涉及诊断为2型糖尿病的肥胖患者的有关减肥实践的随机III期临床试验中的招募,保留和依从性报告。
机译:III期随机试验的事后分析:先前报道的接受强度调节放疗的鼻咽癌患者放射诱发甲状腺功能减退的预测因子的验证
机译:将佐剂单剂S1,S-1与S-1和Oxaliplatin的随机阶段III试验比较D2切除后的节点阳性胃癌患者的术后校长:艺术家2试验☆